Clinical Cohort Study in Patients With Different Subtypes of Primary Sjogren Syndrome Related Dry Eye

Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome

NCT05605665 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome

NCT02011776 ·Status: COMPLETED

Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome

NCT02370550 ·Status: UNKNOWN ·Phase: PHASE4

To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome

NCT04877483 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

NCT02067910 ·Status: COMPLETED ·Phase: PHASE3

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease

NCT07281456 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome

NCT06544642 ·Status: TERMINATED ·Phase: PHASE1

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

NCT02464319 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

NCT06766357 ·Status: RECRUITING ·Phase: PHASE3

AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye

NCT06013436 ·Status: COMPLETED

A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome

NCT00852839 ·Status: COMPLETED ·Phase: PHASE2

Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye

NCT04493658 ·Status: COMPLETED

Low Dose Cyclosporin A in Primary Sjögren Syndrome

NCT01693393 ·Status: COMPLETED ·Phase: PHASE2

Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome

NCT05781451 ·Status: WITHDRAWN ·Phase: PHASE2

The Beijing Adult Dry Eye Cohort Study

NCT06621446 ·Status: ACTIVE_NOT_RECRUITING

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome

NCT04684654 ·Status: TERMINATED ·Phase: PHASE1

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome

NCT02775916 ·Status: COMPLETED ·Phase: PHASE2

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

NCT03865888 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops

NCT00001731 ·Status: COMPLETED ·Phase: PHASE2

Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

NCT00542763 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

NCT05946941 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome

NCT05383677 ·Status: UNKNOWN ·Phase: PHASE2

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

NCT06684847 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

NCT07277257 ·Status: RECRUITING ·Phase: PHASE4